Print ISSN: 2394-6369
Online ISSN: 2394-6377
CODEN : IJCBK6
International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Original Article
Author Details :
Volume : 4, Issue : 2, Year : 2017
Article Page : 106-110
Abstract
Introduction: There is need of precise and faster diagnosis for pulmonary (PTB) and extra-pulmonary tuberculosis (EPTB). Accordingly, there develops a considerable interest in the development of tests based on biochemical response of body towards tuberculosis infection (i.e. estimation of serum adenosine deaminase). These tests appear to be a promising approach for the diagnosis of pulmonary as well as extra pulmonary TB.
Materials & Method: Total 150 individuals recruited for this study, out of which 50 cases each of PTB and EPTB. 50 age and sex matched controls were included, out of which 15 were healthy controls and 35 were diseased controls. Serum adenosine deaminase (ADA) was estimated by using commercial ADA-MTB kit.
Results: Serum ADA concentration in patients with PTB & EPTB was found to be significantly higher (p < 0.05) as compared to diseased and healthy controls.
Conclusion: Our observations suggest that serum Adenosine deaminase (ADA) measurement has a good detection potential for PTB & EPTB.
Keywords: Adenosine Deaminase, Pulmonary and Extra-Pulmonary Tuberculosis
How to cite : Ninghot A, Mohod K, Kumar S, Evaluation of Serum Adenosine Deaminase (ADA) Values for Detection of Pulmonary and Extra-pulmonary Tuberculosis. Int J Clin Biochem Res 2017;4(2):106-110
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.